Record Revenue and Growth
Doximity delivered $169 million in revenue for the second quarter of fiscal 2026, representing a 23% year-on-year growth and a 7% beat from the high end of their guidance range.
Strong Financial Performance
Adjusted EBITDA margin was 60% or $101 million, 15% above the high end of guidance and grew 32% year-on-year. Free cash flow increased by 37% year-on-year.
AI and Workflow Tool Adoption
AI tools saw quarterly active prescribers up more than 50% from the prior quarter. The new AI scribe saw its number of quarterly active users nearly triple versus Q1.
Successful Pathway Acquisition Integration
Pathway's entire medical data set and AI models were fully integrated into DoxGPT just 7 weeks after acquisition, enhancing AI capabilities.
Client Engagement and Expansion
Net revenue retention rate of 118% and 121 customers contributing at least $500,000 each, up 16% from the previous year. Bookings growth in SMB customers was up roughly 100% year-over-year in Q2.